Clinical Trial Update: A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A study comparing trastuzumab emtansine to a taxane in HER2-positive advanced gastric cancer was terminated, and the results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Kadcyla (trastuzumab emtansine) (trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-08-11